Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study
- Author(s)
- Ebrahimi, A; Gupta, R; McDowell, L; Magarey, MJR; Smith, PN; Schulte, KM; Perriman, DM; Veness, M; Porceddu, S; Low, TH; Fowler, A; Clark, JR;
- Journal Title
- Head & Neck
- Publication Type
- Online publication before print
- Abstract
- BACKGROUND: We aimed to identify predictors of distant metastatic recurrence (DMR) in patients with head and neck cutaneous squamous cell carcinoma (HNcSCC) with nodal metastases treated with curative intent. METHODS: Predictors of DMR were identified using Cox regression in a multicenter study of 1151 patients. RESULTS: The 5-year risk of DMR was 9.6%. On multivariate analysis, immunosuppression (HR 2.93; 95% CI: 1.70-5.05; p < 0.001), nodal size >6 cm [versus ≤3 cm (HR 2.77; 95% CI: 1.09-7.03; p = 0.032)], ≥5 nodal metastases [versus 1-2 (HR 2.79; 95% CI: 1.63-4.78; p < 0.001)], and bilateral disease (HR 3.11; 95% CI: 1.40-6.90; p = 0.005) predicted DMR. A DMR risk score was developed that stratified risk from 6.6% (no risk factors) to 100% (≥3 risk factors) (p < 0.001). CONCLUSIONS: The risk of DMR in nodal metastatic HNcSCC increases with immunosuppression, nodal size >6 cm, ≥5 nodal metastases, and bilateral disease. A simple DMR risk score estimated prior to treatment may be clinically useful.
- Keywords
- cutaneous squamous cell carcinoma; distant metastases; head and neck cancer; lymph node metastasis; prognosis
- Department(s)
- Radiation Oncology; Surgical Oncology
- Publisher's Version
- https://doi.org/10.1002/hed.27912
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-09-10 04:36:57
Last Modified: 2024-09-10 04:41:31